✦ LIBER ✦

Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pituitary suppression

✍ Scribed by Mario Cavagna; Luiz Guilherme Louzada Maldonado; Tatiana Carvalho de Souza Bonetti; Daniela Paes de Almeida Ferreira Braga; Assumpto Iaconelli Jr.; Edson Borges Jr.

Book ID: 116475043
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 112 KB
Volume: 94
Category: Article
ISSN: 1556-5653
DOI: 10.1016/j.fertnstert.2009.02.075

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Triggering final oocyte maturation using

Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone

✍ Efstratios M. Kolibianakis; Evangelos G. Papanikolaou; Herman Tournaye; Michel C 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Clinical Assisted Reproduction: The Effe

Clinical Assisted Reproduction: The Effect of Exogenous Luteinizing Hormone (LH) on Oocyte Viability: Evidence from a Comparative Study Using Recombinant Human Follicle-Stimulating Hormone (FSH) Alone or in Combination with Recombinant LH for Ovarian Stimulation in Pituitary-Suppressed Women Undergoing Assisted Reproduction

✍ Juan Balasch; Montserrat Creus; Francisco Fábregues; Salvadora Civico; Francisco 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 65 KB